ID
40987
Beschreibung
The primary focus of this first time in human (FTIH) study was to evaluate the safety and tolerability of GSK1292263 and to estimate GSK1292263 pharmacokinetic (PK) parameters and pharmacodynamic (PD) effects in healthy volunteers. Subject: FTIH, oral, safety, tolerability, pharmacokinetics, glucose, pharmacodynamics, male, female, gastric emptying Indication Studied: Type 2 Diabetes Mellitis Study ID: 111596 Clinical Study ID: 111596 Study Title: A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00783549 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK1292263, Sitagliptin Trade Name: N/A Study Indication: Dyslipidaemias
Stichworte
Versionen (1)
- 07.06.20 07.06.20 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
7. Juni 2020
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin
Pharmacodynamics - (mOGTT - Blood) V6 11-DF
- StudyEvent: ODM
Beschreibung
10 minutes pre-glucose
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Beschreibung
Pre-glucose
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Beschreibung
10 minutes post
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Beschreibung
20 minutes post
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Beschreibung
30 minutes post
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Beschreibung
60 minutes post
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Beschreibung
90 minutes post
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Beschreibung
120 minutes post
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Beschreibung
180 minutes post
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Ähnliche Modelle
Pharmacodynamics - (mOGTT - Blood) V6 11-DF
- StudyEvent: ODM
C0808070 (UMLS CUI-2)
C1301880 (UMLS CUI-3)
C0017725 (UMLS CUI-4)
C0017725 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])